GROENHUYSEN WILHELMUS CM has filed 21 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1055 shares of NovoCure Ltd ($NVCR) on June 28, 2024.
Activity breakdown: 0 open-market purchases and 9 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 28, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 1055 | $12.24 | 252,290.0000 | 0 | 0.42% | 0.00% |
| June 5, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | M | Ordinary Shares | 124373 | $22.82 | 375,608.0000 | 0 | 49.50% | 0.00% |
| June 5, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | M | Stock Options (Right to buy) | 124373 | $22.82 | 95,000.0000 | 0 | 56.69% | 0.00% |
| March 1, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 2107 | $16.03 | 252,452.0000 | 0 | 0.83% | 0.00% |
| March 4, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 1217 | $16.01 | 251,235.0000 | 0 | 0.48% | 0.00% |
| Dec. 31, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 3 | $12.69 | 209,828.0000 | 0 | 0.00% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 47034 | $16.30 | 256,862.0000 | 0 | 22.42% | 0.00% |
| Feb. 28, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 2303 | $16.14 | 254,559.0000 | 0 | 0.90% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Stock Options (Right to buy) | 71920 | $16.30 | 71,920.0000 | 0 | 9999.99% | 0.00% |
| Sept. 1, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 294 | $21.82 | 209,825.0000 | 0 | 0.14% | 0.00% |
| June 30, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 366 | $35.28 | 210,119.0000 | 0 | 0.17% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 3528 | $76.16 | 231,860.0000 | 0 | 1.50% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 1692 | $76.16 | 230,168.0000 | 0 | 0.73% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 20415 | $76.16 | 209,753.0000 | 0 | 8.87% | 0.00% |
| March 2, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 1213 | $75.28 | 183,402.0000 | 0 | 0.66% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 48050 | $0.00 | 231,452.0000 | 0 | 26.20% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 3936 | $0.00 | 235,388.0000 | 0 | 1.70% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 21653 | $0.00 | 186,779.0000 | 0 | 13.11% | 0.00% |
| March 1, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | S | Ordinary Shares | 2164 | $76.36 | 184,615.0000 | 0 | 1.16% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Options to Buy Ordinary Shares | 36013 | $76.97 | 36,013.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | NovoCure Ltd | $NVCR | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | A | Ordinary Shares | 102 | $62.31 | 165,126.0000 | 0 | 0.06% | 0.00% |